Xie and colleagues showed that calcium-sensitive receptor (CasR) activation triggered TRPV4-mediated Ca2+ entry, followed by Akt and β-catenin phosphorylation and tumor progression [103]. The gene discussed is TRPV4; the disease is neoplasm.